arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 7/2018 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Priority for generic names (INN) … also on drug packages

    NEW ON THE MARKET

    Bezlotoxumab (ZINPLAVA) for recurrence prevention of Clostridium difficile associated diarrhea

    Rosuvastatin plus ezetimibe (ANTILIA, ROSUZET)

    a-t READERS QUESTIONS AND COMMENTS

    Are cognitive impairment or dementia adverse effects of statins?

    Vaccination in patients with hereditary fructose intolerance

    IN BRIEF

    Lenience towards the pharmaceutical industry – warnings on packages of over-the-counter analgesics

    CURRENT ADR NETWORK REPORT

    Withdrawal syndrome following discontinuation of venlafaxin (TREVILOR, generics)

    SIDE EFFECTS

    Multiple vertebral fractures after discontinuation of denosumab as XGEVA
    free

    Uterine fibroids: new restrictions of use for ulipristal acetate (ESMYA)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles